Inspire Medical Systems, Inc.
Inspire Medical Systems Announces Strong Second Quarter Results and Raises Revenue Guidance for 2024
Summary
Inspire Medical Systems, Inc. announced preliminary, unaudited results for the second quarter of 2024, showing a 30% increase in revenue to $195.9 million. The company also updated its full-year 2024 revenue guidance to a range of $788 million to $798 million, representing a 26% to 28% growth over 2023. This announcement was made via a press release on July 29, 2024.
Profitelligence Alerts
Get alerts for INSP
Be first to know when Inspire Medical Systems, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neurostimulation device that provides a unique and effective solution for patients who are unable to utilize traditional continuous positive airway pressure (CPAP) devices. Inspire Medical Systems significantly impacts the healthcare sector by offering a less invasive, patient-friendly alternative to surgical treatments for OSA, improving quality of life for those affected by sleep disorders. Headquartered in Minnesota, Inspire Medical Systems continues to expand its presence within the medical device market, collaborating closely with hospitals and medical professionals to enhance sleep health management globally. This company's contributions underscore a growing focus on personalized and technologically advanced approaches to medical challenges, marking its importance in the evolving landscape of healthcare solutions.
Official SEC Documents
Advertisement